Carbonxt Group Past Earnings Performance
Past criteria checks 0/6
Carbonxt Group has been growing earnings at an average annual rate of 2.5%, while the Chemicals industry saw earnings growing at 6.6% annually. Revenues have been growing at an average rate of 0.4% per year.
Key information
2.5%
Earnings growth rate
29.5%
EPS growth rate
| Chemicals Industry Growth | 14.4% |
| Revenue growth rate | 0.4% |
| Return on equity | -54.1% |
| Net Margin | -44.7% |
| Last Earnings Update | 31 Dec 2023 |
Recent past performance updates
Recent updates
Carbonxt Group Limited's (ASX:CG1) Share Price Boosted 34% But Its Business Prospects Need A Lift Too
Jan 22
Shareholders Will Likely Find Carbonxt Group Limited's (ASX:CG1) CEO Compensation Acceptable
Nov 20Is Carbonxt Group (ASX:CG1) A Risky Investment?
Nov 03Carbonxt Group Limited (ASX:CG1) Surges 29% Yet Its Low P/S Is No Reason For Excitement
Aug 26Is Carbonxt Group (ASX:CG1) Using Debt In A Risky Way?
Jun 09Does Carbonxt Group (ASX:CG1) Have A Healthy Balance Sheet?
Aug 31Carbonxt Group (ASX:CG1) Is Carrying A Fair Bit Of Debt
Dec 07Here's Why Carbonxt Group (ASX:CG1) Can Afford Some Debt
May 04Here's What We Think About Carbonxt Group's (ASX:CG1) CEO Pay
Jan 19Revenue & Expenses BreakdownBeta
How Carbonxt Group makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 23 | 15 | -7 | 6 | 0 |
| 30 Sep 23 | 15 | -6 | 6 | 0 |
| 30 Jun 23 | 15 | -6 | 6 | 0 |
| 31 Mar 23 | 16 | -6 | 7 | 0 |
| 31 Dec 22 | 17 | -5 | 7 | 0 |
| 30 Sep 22 | 18 | -5 | 7 | 0 |
| 30 Jun 22 | 18 | -4 | 6 | 0 |
| 31 Mar 22 | 17 | -5 | 6 | 0 |
| 31 Dec 21 | 15 | -5 | 6 | 0 |
| 30 Sep 21 | 14 | -5 | 6 | 0 |
| 30 Jun 21 | 12 | -5 | 6 | 0 |
| 31 Mar 21 | 13 | -5 | 6 | 0 |
| 31 Dec 20 | 15 | -5 | 7 | 0 |
| 30 Sep 20 | 15 | -5 | 7 | 0 |
| 30 Jun 20 | 16 | -4 | 7 | 0 |
| 31 Mar 20 | 17 | -4 | 6 | 0 |
| 31 Dec 19 | 18 | -3 | 6 | 0 |
| 30 Sep 19 | 18 | -5 | 7 | 0 |
| 30 Jun 19 | 18 | -7 | 7 | 0 |
| 31 Mar 19 | 15 | -8 | 8 | 0 |
| 31 Dec 18 | 12 | -9 | 9 | 0 |
| 30 Sep 18 | 9 | -8 | 8 | 0 |
| 30 Jun 18 | 6 | -7 | 8 | 0 |
| 31 Mar 18 | 6 | -6 | 6 | 0 |
| 31 Dec 17 | 5 | -5 | 5 | 0 |
| 30 Sep 17 | 5 | -5 | 4 | 0 |
| 30 Jun 17 | 4 | -4 | 4 | 0 |
| 30 Jun 16 | 1 | -5 | 2 | 0 |
| 30 Jun 15 | 0 | -4 | 2 | 0 |
Quality Earnings: CG1 is currently unprofitable.
Growing Profit Margin: CG1 is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: CG1 is unprofitable, but has reduced losses over the past 5 years at a rate of 2.5% per year.
Accelerating Growth: Unable to compare CG1's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: CG1 is unprofitable, making it difficult to compare its past year earnings growth to the Chemicals industry (-53.6%).
Return on Equity
High ROE: CG1 has a negative Return on Equity (-54.06%), as it is currently unprofitable.